The Joint Corp. (United States)

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US47973J1025
USD
8.45
0.18 (2.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1236574,
    "name": "The Joint Corp. (United States)",
    "stock_name": "The Joint Corp. (United States)",
    "full_name": "The Joint Corp. (United States)",
    "name_url": "stocks-analysis/the-joint-corp-united-states",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "8.45",
    "chg": 0.18,
    "chgp": "2.18%",
    "dir": 1,
    "prev_price": "8.27",
    "mcapval": "163.59",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 3365,
    "indexname": "S&P 500",
    "isin": "US47973J1025",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "205.77 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/the-joint-corp-united-states-1236574-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "The Joint Corp. Stock Plummets to New 52-Week Low at $7.50",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/the-joint-corp-stock-plummets-to-new-52-week-low-at-750-3686467",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TheJointCorpUni_priceRelatedfactors_3686467.png",
        "date": "2025-11-10 17:18:34",
        "description": "The Joint Corp. has reached a new 52-week low, reflecting a significant decline of 48.45% over the past year, contrasting with the S&P 500's gains. The company, with a market cap of USD 164 million, faces challenges indicated by negative return on equity and a high price-to-book ratio."
      },
      {
        "title": "The Joint Corp. Hits New 52-Week Low at $7.69 Amid Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/the-joint-corp-hits-new-52-week-low-at-769-amid-decline-3674049",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TheJointCorpUni_priceRelatedfactors_3674049.png",
        "date": "2025-11-05 16:48:17",
        "description": "The Joint Corp., a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 7.69, reflecting a challenging year with a 46.98% decline in stock price. The company has a market cap of USD 164 million and shows negative financial metrics, including a return on equity of -13.76%."
      },
      {
        "title": "The Joint Corp. Hits 52-Week Low at $7.74 Amidst Significant Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/the-joint-corp-hits-52-week-low-at-774-amidst-significant-decline-3667328",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TheJointCorpUni_priceRelatedfactors_3667328.png",
        "date": "2025-11-03 17:14:33",
        "description": "The Joint Corp. has reached a new 52-week low, reflecting a challenging year with a significant performance decline. Despite a reported profit increase, the company's financial metrics indicate a complex structure, including a negative return on equity and a high price-to-book ratio, contributing to its current market position."
      },
      {
        "title": "The Joint Corp. Hits New 52-Week Low at $7.78 Amid Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/the-joint-corp-hits-new-52-week-low-at-778-amid-decline-3662008",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TheJointCorpUni_priceRelatedfactors_3662008.png",
        "date": "2025-10-31 16:24:49",
        "description": "The Joint Corp. has reached a new 52-week low of USD 7.78, reflecting a challenging year with a 46.98% decline from its high of USD 13.47. Despite a 44.8% increase in profits, the company has struggled with negative stock performance and underperformed against the S&P 500."
      },
      {
        "title": "The Joint Corp. Stock Plummets to New 52-Week Low at $8.62",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/the-joint-corp-stock-plummets-to-new-52-week-low-at-862-3608047",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TheJointCorpUni_priceRelatedfactors_3608047.png",
        "date": "2025-10-09 20:20:30",
        "description": "The Joint Corp. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. With a market capitalization of USD 164 million, the company faces financial challenges, including a negative return on equity and a high price-to-book ratio, indicating ongoing difficulties in the market."
      },
      {
        "title": "The Joint Corp. Hits 52-Week Low at $8.67 Amidst Ongoing Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/the-joint-corp-hits-52-week-low-at-867-amidst-ongoing-struggles-3604365",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TheJointCorpUni_priceRelatedfactors_3604365.png",
        "date": "2025-10-08 16:54:07",
        "description": "The Joint Corp., a microcap in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low of USD 8.67 as of October 7, 2025. The company has a market cap of USD 164 million and operates at a loss, with significant financial challenges reflected in its ratios and stock performance."
      },
      {
        "title": "The Joint Corp. Hits 52-Week Low at USD 8.74 Amid Declining Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/the-joint-corp-hits-52-week-low-at-usd-874-amid-declining-performance-3601665",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TheJointCorpUni_priceRelatedfactors_3601665.png",
        "date": "2025-10-07 21:56:12",
        "description": "The Joint Corp., a microcap in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low, reflecting a 40.66% decline over the past year. With a market cap of USD 164 million, the company faces financial challenges, including negative earnings and a high price-to-book ratio."
      },
      {
        "title": "The Joint Corp. Hits New 52-Week Low at $8.93 Amid Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/the-joint-corp-hits-new-52-week-low-at-893-amid-decline-3595665",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TheJointCorpUni_priceRelatedfactors_3595665.png",
        "date": "2025-10-06 17:38:24",
        "description": "The Joint Corp. has reached a new 52-week low of USD 8.93, reflecting a significant decline in its stock price, which has dropped by nearly 39% over the past year. Despite a 44.8% increase in profits, the company continues to face challenges in the market."
      },
      {
        "title": "The Joint Corp. Stock Plummets to New 52-Week Low at $9.06",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/the-joint-corp-stock-plummets-to-new-52-week-low-at-906-3588395",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TheJointCorpUni_priceRelatedfactors_3588395.png",
        "date": "2025-10-02 22:38:37",
        "description": "The Joint Corp. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year, contrasting with the S&P 500's gains. The company operates at a loss, with a high price-to-book ratio and negative return on equity, indicating financial challenges despite increased profits."
      }
    ],
    "total": 17,
    "sid": "1236574",
    "stock_news_url": "https://www.marketsmojo.com/news/the-joint-corp-united-states-1236574"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock newsNews and Views
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available